Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κBLEVATI, Lauretta; RUFFINI, Federica; MUZI, Alessia et al.International journal of oncology. 2011, Vol 38, Num 1, pp 241-247, issn 1019-6439, 7 p.Article

The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanomaTENTORI, Lucio; SUSANNA DORIO, Annalisa; MUZI, Alessia et al.Oncology reports. 2008, Vol 19, Num 4, pp 1039-1043, issn 1021-335X, 5 p.Article

Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cellsMIGUEL LACAL, Pedro; TENTORI, Lucio; MUZI, Alessia et al.International journal of oncology. 2009, Vol 34, Num 3, pp 861-872, issn 1019-6439, 12 p.Article

A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through α5β1 integrinSORO, Simonetta; ORECCHIA, Angela; TRAMONTANO, Anna et al.Blood. 2008, Vol 111, Num 7, pp 3479-3488, issn 0006-4971, 10 p.Article

Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomideTENTORI, Lucio; LEONETTI, Carlo; JIE ZHANG et al.European journal of cancer (1990). 2005, Vol 41, Num 18, pp 2948-2957, issn 0959-8049, 10 p.Article